GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference

GRAIL (Nasdaq: GRAL) announced that company management will present at the 7th Annual Wolfe Research Healthcare Conference on Tuesday, Nov. 18, 2025 at 10:00 a.m. ET.

Rhea-AI Summary

GRAIL (Nasdaq: GRAL) announced that company management will present at the 7th Annual Wolfe Research Healthcare Conference on Tuesday, Nov. 18, 2025 at 10:00 a.m. ET.

Live and replay webcasts will be available via the company's investor relations site at investors.grail.com, and the webcast will be archived and available for replay for at least 30 days after the event.

Argus Nov 5 session

+4.90% close to close 0.7x rel. volume Open Argus

Details

News Market Reaction – GRAL

On Nov 5, the first trading day after this news, GRAL closed 4.90% above the previous close.

Data tracked by StockTitan Argus for the Nov 5 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MENLO PARK, Calif., Nov. 4, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 7th Annual Wolfe Research Healthcare Conference on Tuesday, Nov. 18 at 10:00 a.m. ET. 

Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-7th-annual-wolfe-research-healthcare-conference-302604500.html

SOURCE GRAIL, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will GRAIL (GRAL) present at the Wolfe Research Healthcare Conference?

GRAIL will present on Tuesday, Nov. 18, 2025 at 10:00 a.m. ET.

How can investors watch the GRAIL (GRAL) presentation on Nov. 18, 2025?

Investors can access the live webcast and replays via the investor relations site at investors.grail.com.

Will the GRAIL (GRAL) webcast be available after the Wolfe Research conference?

Yes, the webcast will be archived and available for replay for at least 30 days after the event.

Where on the GRAIL website will the Wolfe Research webcast appear?

The webcast will be posted in the Investor Relations section of investors.grail.com.

Is there any fee or special registration mentioned to view the GRAIL (GRAL) webcast?

No fee or special registration is mentioned; the announcement directs viewers to the investor relations site.

What time zone is used for the GRAIL (GRAL) conference presentation time?

The presentation time is shown in Eastern Time (ET).